Fundraising FoxGemstone BioTherapeutics
Baltimore, US · Founded 2013 · Maryland LLC
Find your way into Gemstone BioTherapeutics
95 people in our graph share verified history with the Gemstone BioTherapeutics team — schools, employers, funds. One of them is your warm intro.
Ian Tolfreeunlockedknows George Davis · together at Gemstone BioTherapeutics (overlapped)
×2knows the team · via Astek Diagnostics
knows the team · via Aether Systems
×2knows the team · via Evergreen Advisors
×5knows the team · via Porter
knows the team · via Maryland Technology Development Corporation (TEDCO)
Founders & leadership
GD
George DavisCEO2013–2017George Davis is a Chief Executive Officer at Gemstone BioTherapeutics with prior experience in venture capital and private equity, and expertise in business development across technology and biotechnology sectors.
SG
Sharon GerechtNamed on SEC filing
Board
DO
David OrosBoard director
XH
Xin HuangBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 2 rounds · 2015–2016
▶$700KraisedOct 2016 · 5 investors · BiotechnologyRule 506(b)
▶$700KraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George DavisExecutive Officer, Director, Promoter
- David OrosDirector, Promoter
- GEOFF MACKAYDirector
- Xin HuangDirector
- Offering amount
- $3.5M
- Amount sold
- $700K
- Minimum investment
- $100K
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Maryland, 2013
- Federal exemptions
- 06b
▶$1.6MraisedJun 2015 · 3 investors · BiotechnologyRule 506(b)
▶$1.6MraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sharon GerechtDirector
- George DavisExecutive Officer, Director, Promoter
- Xin HuangDirector
- David OrosDirector, Promoter
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $100K
- First sale
- Jun 2015
- Incorporated
- Limited Liability Company, Maryland, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gemstone BioTherapeutics raised?
- Gemstone BioTherapeutics has disclosed $2.3M raised across 2 rounds.
- Where is Gemstone BioTherapeutics headquartered?
- Gemstone BioTherapeutics is headquartered in Baltimore, US.